systemic lupus erythematosus
CD72: A Potential Target For Treating Autoimmune Disease
Scientists have identified a molecule that blocks the immune system from mistakenly reacting with itself.
Immune-Boosting Drug Shows Promise For Treating Lupus
A drug used in immunotherapy could help suppress the overactive immune system of lupus patients in much lower doses, a study suggests.
Scientists Identify New Gene Regions That Increase Risk Of Lupus
Ten new gene regions that confer increased susceptibility to lupus have been identified in Asians.
Lilly & Hanmi Ink US$690 Million Deal
Eli Lilly has acquired Hanmi's BTK inhibitor HM71224, a small molecule soon to enter Phase II trials for autoimmune diseases.
MacroGenics & Takeda Develop Bi-Specific Antibodies For Autoimmune Diseases
MGD010, which simultaneously targets the cell surface receptors CD32B and CD78B, could help modulate B cell function without causing depletion.
Takeda And Resolve Therapeutics To Develop Lupus Treatments
Takeda Pharma and Resolve Therapeutics have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases.
